You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The grant was awarded as part of DARPA's Epigenetic Characterization and Observation program, which aims to develop new approaches to epigenetic analysis.
The researchers are aiming to find molecular signatures in blood that identify previous exposures to materials associated with weapons of mass destruction.
The Biomedical Advanced Research and Development Authority aims to produce at least two US Food and Drug Administration-cleared tests.
DxTerity aims to develop a genomic blood test to identify which cancer patients are most likely to benefit from radiation therapy or are at risk for toxicity.
With exome sequences, RNA sequences, and methylation profiles, investigators uncovered differences between radiation-induced and sporadic forms of meningioma.
The developers said such a signature could help triage people exposed to radiation through war, a terrorist attack, or an industrial accident.
In Science this week: DNA Fountain for storing data in DNA, and more.
The firm plans to seek Emergency Use Authorization for the 18-gene panel and will subsequently submit it to the FDA for full approval.
Genome sequencing suggests secondary tumors present after ionizing radiation treatment tend to contain numerous deletions and balancing inversions.
The additional funds bring the total contract to $43 million over approximately eight years.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.